Immediate Impact

3 by Nobel laureates 6 from Science/Nature 72 standout
Sub-graph 1 of 22

Citing Papers

[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study
2024 Standout
Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
2023 StandoutNobel
10 intermediate papers

Works of Michael Böhmig being referenced

Angiopoietin‐2 drives lymphatic metastasis of pancreatic cancer
2011
Prospective, Randomized, Multicenter Trial on the Antiproliferative Effect of Lanreotide, Interferon Alfa, and Their Combination for Therapy of Metastatic Neuroendocrine Gastroenteropancreatic Tumors—The International Lanreotide and Interferon Alfa Study Group
2003
and 1 more

Author Peers

Author Last Decade Papers Cites
Michael Böhmig 970 824 580 23 1.4k
Gaspard d’Assignies 442 651 175 30 1.2k
William J. Schirmer 606 593 365 33 1.1k
Igor Latich 749 852 538 29 1.2k
J L Doppman 290 413 300 40 1.7k
Philippe Brunner 651 754 532 49 1.6k
Nick Reed 816 704 390 36 1.6k
Irvin Modlin 541 651 415 28 1.2k
Leena‐Maija Soveri 896 690 473 13 1.0k
Henning Jann 1041 1108 700 58 1.3k
Marina Djurfeldt 442 147 203 31 1.1k

All Works

Loading papers...

Rankless by CCL
2026